<<

View metadata, citation and similar papers at core.ac.uk brought to you by CORE 2150 Letters to the Editor JACCprovided Vol. by 43, Elsevier No. 11, - Publisher 2004 Connector June 2, 2004:2147–51

populations and the heterogeneous etiology of the recurrent half-life of sildenafil, the gold standard 5 pericarditis. Clearly, there is a need for an international, random- (PDE5) inhibitor is not provided. This would be useful, including ized study to test the effectiveness of colchicine and other treat- the best estimate of its duration of its action, as well as the time ments, for example, intrapericardial triamcinolone administration period during which there is a potentially hazardous interaction tested by Maisch et al. (3). The evaluation of the effectiveness of between this PD5 inhibitor and . 5) Is it possible that an treatments is difficult on the basis of single cases, as the course of acute dosing interaction (no previous exposure for several days) recurrent pericarditis is unpredictable although gradually “burning with nitrates with sildenafil or tadalafil might induce a different out.” The chronicity of the condition is exemplified by two of our response to nitrates than after 5 to 6 consecutive half-lives of the patients believed to be cured of the disease, but who after the PD5 inhibition? Thus, it may be that a form of tolerance to acceptance of our article have had new relapses after 9 and 11 years’ hemodynamic effects could develop within days in the vasculature, quiescence, respectively. attenuating the decrease in blood pressure and increase in heart Similar to Dr. Brucato and his colleagues, we find it important rate after an individual has been taking a PD5 inhibitor for a to use as nontoxic drugs as possible during the acute phases of considerable amount of time, as in this experiment. The protocol pericarditis. However, our experience in young patients does not design does not really mirror the way sildenafil and tadalafil are support their recommendation of routine multidrug therapy in- used in daily living. It would be useful to know if there are data cluding long-term corticosteroids, colchicine, and NSAIDs. In our that answer these questions. hands, mere NSAID treatment was in the long run at least as effective as the treatment with different immunosuppressive drugs. Jonathan Abrams, MD Division of Cardiology Marja Raatikka, MD University of New Mexico, School of Medicine Pirkko M. Pelkonen, MD Ambulatory Care Building, 5th Floor Eero Jokinen, MD 2211 Lomas Boulevard NE Jouko Karjalainen, MD Albuquerque, New Mexico 87131 Central Military Hospital E-mail: [email protected] Box 50, 00301 doi:10.1016/j.jacc.2004.03.008 Helsinki Finland REFERENCE E-mail: [email protected].fi

doi:10.1016/j.jacc.2004.03.017 1. Kloner RA, Hutter AM, Emmick JT, et al. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol 2003;42: 1855–60. REFERENCES

1. Raatikka M, Pelkonen PM, Karjalainen J, Jokinen EV. Recurrent REPLY pericarditis in children and adolescents: report of 15 cases. J Am Coll Cardiol 2003;42:759–64. We would like to thank Dr. Abrams for his questions regarding 2. Adler Y, Finkelstein Y, Guindo J, et al. Colchicine treatment for our study on the time course of the interaction between tadalafil recurrent pericarditis: a decade of experience. Circulation 1998;97: and sublingual (SL-NTG) (1). In response to ques- 2183–5. 3. Maisch B, Ristic AD, Pancuweit S. Intrapericardial treatment of tion 1 regarding the duration of efficacy: Since the publication of autoreactive pericardial effusion with triamcinolone. The way to avoid the article (1), tadalafil, a phosphodiesterase 5 (PDE5) inhibitor, side effects of systemic corticosteroid therapy. Eur Heart J 2002;23: has been approved by the Food and Drug Administration for the 1503–8. treatment of (ED) (2). Tadalafil improves erectile function in men with ED for up to 36 h after dosing (2,3). Therefore, the duration of efficacy of tadalafil for the treatment of ED for up to 36 h is similar to the time course of the interaction Time Course of the Interaction of tadalafil with nitrates (i.e., the hemodynamic interaction be- Between Tadalafil and Nitrates tween tadalafil and SL-NTG lasted 24 h but was not seen at 48 h and beyond). The Express Publication by Kloner et al. (1) on the interactions In response to question 2 regarding study design: Our study was between nitrates and tadalafil should be of interest to all cardiol- a randomized, placebo-controlled, double-blind, two-period, ogists and physicians seeing patients with acute chest pain. cross-over, multicenter study (n ϭ 150). During treatment period However, I have several questions: 1) What is the duration of 1, subjects received seven consecutive daily doses of either tadalafil erectile dysfunction efficacy of tadalifil? The long half-life suggests (20 mg) or placebo before SL-NTG administration. After a 10- to that responsiveness to the drug may last 2 to 3 days; do we know 21-day washout period, subjects were crossed over to the opposite whether the blood pressure and heart rate effects of nitrates with treatment (treatment period 2) and received seven consecutive tadalafil on board are concordant with the duration of improve- daily doses of either tadalafil or placebo before SL-NTG admin- ment in sexual function? 2) It is unclear whether there is a repeat istration. run-in of 7 days for both placebo and tadalafil after the cross-over, In response to question 3 regarding the recommendation to that is, is the second-half dosing the same as the first part of the withhold nitrates for 48 h: In our study, SL-NTG (0.4 mg) was protocol? 3) Why is the recommendation made to withhold administered at 2, 4, 8, 24, 48, 72, and 96 h after the last dose of concomitant use of a nitrate and tadalafil for 48 h when all data tadalafil 20 mg or placebo. Tadalafil augmented the blood robustly support no interaction at this time interval? 4) The pressure-lowering effects of SL-NTG from 2 to 24 h post-dosing